management of residual disease in triple negative breast cancer
Published 6 months ago • 80 plays • Length 0:43Download video MP4
Download video MP3
Similar videos
-
5:47
the meaning of residual disease in breast cancer
-
1:48
residual tumor treatment in mutant brca-1 triple-negative breast cancer
-
4:20
keynote-522: 5-year follow-up of pembrolizumab in triple-negative breast cancer
-
1:16
tackling residual disease in breast cancer
-
1:56
keynote-522: optimal preoperative io and residual disease management in tnbc
-
1:35
issues in triple negative breast cancer: 2023 best of breast conference
-
27:03
triple negative breast cancer: predictive and prognostic biomarkers for neo/adjuvant therapy
-
0:37
management for residual disease in tnbc after chemo-immunotherapy
-
3:53
ki-67: explained!!! #medschooldiscussion
-
13:38
near complete remission in stage 4 triple negative breast cancer | #integrativeoncology | aohc
-
4:12
immunotherapy for cancer: pembrolizumab #cancer #immunotherapy #malignancy
-
46:31
adjuvant therapy | 2023 best of breast conference
-
5:53
treating early-stage tnbc
-
2:05
treatment advances in tnbc
-
1:00:46
triple negative breast cancer case panel discussion | 2022 best of breast conference
-
20:55
lightning updates | 2023 best of breast conference
-
1:29
takeaways on the management of early-stage tnbc
-
0:56
pembrolizumab as adjuvant therapy for tnbc
-
4:55
triple negative breast cancer: what you need to know
-
1:08:58
tnbc current and emerging therapeutic strategies | 2023 best of breast conference
-
5:21
optimal neoadjuvant and adjuvant therapy for patients with early tnbc
-
2:46
de-escalation of therapy in early-stage tnbc